Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,188 | 63,234 | 33,685 | 51,665 | 50,882 |
| Marketable Securities | 284,536 | 431,011 | 297,502 | 148,931 | 226,012 |
| Receivables | N/A | N/A | 2,066 | 2,081 | 9,362 |
| TOTAL | $362,264 | $505,502 | $340,311 | $209,441 | $290,754 |
| Non-Current Assets | |||||
| PPE Net | 5,525 | 3,567 | 4,486 | 4,606 | 4,321 |
| Other Non-Current Assets | 29,160 | 3,085 | 5,816 | 7,168 | 451 |
| TOTAL | $34,685 | $6,652 | $10,302 | $11,774 | $4,772 |
| Total Assets | $396,949 | $512,154 | $350,613 | $221,215 | $295,526 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,960 | 4,531 | 1,580 | 2,971 | 2,023 |
| Accrued Expenses | 26,716 | 22,675 | 19,876 | 11,991 | 9,576 |
| TOTAL | $33,218 | $28,524 | $23,913 | $16,831 | $11,599 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,211 | 10,054 | 9,929 | N/A | N/A |
| Other Non-Current Liabilities | 29,439 | 0 | 3,429 | 5,325 | 866 |
| TOTAL | $59,650 | $10,054 | $13,358 | $5,325 | $866 |
| Total Liabilities | $92,868 | $38,578 | $37,271 | $22,156 | $12,465 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,236 | 60,239 | 58,940 | 36,114 | 35,738 |
| Common Shares | 6 | 6 | 5 | 3 | 3 |
| Retained earnings | -710,052 | -499,748 | -338,412 | -215,091 | -117,828 |
| Other shareholders' equity | 321 | 345 | -1,958 | -201 | -32 |
| TOTAL | $304,081 | $473,576 | $313,342 | $199,059 | $283,061 |
| Total Liabilities And Equity | $396,949 | $512,154 | $350,613 | $221,215 | $295,526 |